The present study aimed to prepare and evaluate a controlled-release system based on a chitosan scaffold containing selenium nanoparticles loaded with doxycycline. Its topical application in skin wound healing in rats was investigated. Therefore, 80 female rats were used and, after creating experimental skin defects on their back, were randomly divided into four equal groups: the control group without any therapeutic intervention; the second group received a chitosan transdermal patch (Ch); the third group received chitosan transdermal patch loaded with selenium nanoparticles (ChSeN), and the last group received chitosan transdermal patch containing selenium nanoparticle loaded by doxycycline (ChSeND). Morphological and structural characteristics of the synthesized patches were evaluated, and in addition to measuring the skin wound area on days 3, 7, and 21, a histopathological examination was performed. On the third day of the study, less hemorrhage and inflammation and more neo-vascularization were seen in the ChSeND group. Moreover, on day 7, less inflammation and collagen formation were recorded in the ChSeN and ChSeND groups than in the other groups. At the same time, more neo-vascularization and re-epithelialization were seen in the ChSeND group on days 7 and 21. In addition, on day 21 of the study, the most collagen formation was in this group. Examination of the wound area also showed that the lowest area belonged to the ChSeND group. The results showed that the simultaneous presence of selenium nanoparticles and doxycycline in the ChSeND group provided the best repair compared to the control, Ch and ChSeN groups.
7 January 2025 in International Journal of Applied Pharmaceutics
Objective: Breast cancer stands as the most prevalent form of cancer among women globally. Conventional chemotherapy, including the use of 6-Thioguanine (TG), often faces limitations such as poor drug solubility. In this research, we engineered a nanosystem consisting of Mesoporous Silica Nanoparticles (MSNs) loaded with TG and coated with Silk Fibroin (SF) to enhance the pharmacokinetic properties of this drug in targeting the MCF-7 breast cancer cell line. Methods: In this study, we investigated the cytotoxicity of different formulations through MTT assay. Additionally, we analyze apoptosis and cell cycle phase distribution using flow cytometry. Furthermore, the absorption of MSN nanoparticles by MCF-7 cells was investigated using the fluorescent labeling technique by Dil fluorochrome. Results: Our results represented the 48 h Half Maximal Inhibitory Concentration (IC50) values of free TG, MSNs loaded with TG (TG@MSNs) and SF-coated MSNs loaded with TG (SF/TG@MSN) were 16.69, 10.96 and 8.01 μM, respectively. Moreover, the percentage of total early and late apoptosis differed among the treatments. Specifically, cells treated with free TG, TG@MSN and SF/TG@MSN exhibited 13.49%, 76.05% and 84.99% apoptosis, respectively. The results also indicated that administering free TG and TG-loaded MSN nanoparticles to MCF-7 cells resulted in cell cycle arrest at the G2/M phase after 48 h of treatment. Conclusion: Our study demonstrated that the SF/TG@MSN nanosystems effectively increased the cytotoxic effects of TG on the breast cancer cell line.
Influenza neuraminidase (NA) plays a main role in the viral replication of the influenza virus. It has been considered one of the targets for anti-influenza drugs. Anti-influenza drugs such as zanamivir, oseltamivir, and peramivir can fight the virus via the inhibition of NA. However, due to adverse reactions, the resistance of the viral strains and sudden changes in NA inhibitors, the identification of novel inhibitors is needed. Nature products such as berberine have been reported against influenza. In this systematic review, we have focused on the anti-influenza effects of berberine and its main role in the inhibition of NA of the virus. For this aim, "Berberine" was searched with "Influenza" or "flu" or "common cold" or "neuraminidase" in Web of Science, PubMed, Scopus, and Google Scholar databases from 1990 to April 2023. Studies have demonstrated that berberine and its derivatives have a wide range of biological effects such as antiviral effects against viruses like herpes simplex virus, human cytomegalovirus, and influenza A virus. The present study indicates that berberine and some of its derivatives are able to inhibit the influenza virus through NA blockade. Berberine is able to superimpose into the allosteric binding site and shows reversible non-competitive behavior in the ligand-receptor interaction for the inhibition of NA.
25 May 2024 in Journal of Shahrekord University of Medical Sciences
Background and aims: Herpes simplex type 1 (HSV-1) is one of the most common and contagious viruses in humans. Curcumin is a natural polyphenol that produces antiviral effects against various viruses, such as HSVs. Despite curcumin’s numerous effects and benefits, its insolubility has reduced its clinical effectiveness. During recent decades, significant progress has been made in nanodrugs, which has helped expand new delivery systems. This study investigated the in vitro antiviral activity of curcumin-loaded, folic acid-chitosan-coated selenium nanoparticles (SeNP) against HSV-1. Methods: Synthesized SeNPs loaded with curcumin and coated with folic acid-chitosan molecules were used in this experimental study. The studied groups comprised cells and the virus-containing curcumin, acyclovir, and NPs with or without curcumin. The cytotoxicity of the compounds was evaluated on Vero cells using the MTT assay. Antiviral activity was investigated using the MTT colorimetric assay, and the inhibitory effect on HSV-1 was studied using a 50% tissue culture infectious dose assay. Results: The results of this research demonstrated that curcumin (50% inhibitory concentration [IC50]=5.64 µg/mL) and curcumin-loaded SeNPs (IC50=1.15 µg/mL) exhibited satisfactory antiviral potential against HSV-1 in vitro, while curcumin-loaded, folic acid-chitosan-coated SeNPs produced no antiviral effect against HSV-1 due to increased cytotoxicity. Conclusion: Based on the findings, the curcumin and curcumin-loaded SeNPs had acceptable antiviral potential against HSV-1. Loading curcumin with SeNPs makes the compound more active at a lower concentration, and therefore, lower doses can be administered to treat HSV-1 infection.
7 March 2025 in International Journal of Applied Pharmaceutics
Objective: This study investigated the therapeutic potential of chitosan-coated Selenium-Donepezil Nanoparticles (SeNPs) in a scopolamine-induced rat model of Alzheimer's disease (AD). Methods: Chitosan-coated SeNPs were synthesized and characterized using Field Emission Scanning Electron Microscopy (FE-SEM), Dynamic Light Scattering (DLS), Fourier-Transform Infrared Spectroscopy (FTIR), and Energy-Dispersive X-Ray Spectroscopy (EDAX). The therapeutic potential of SeNPs was evaluated in a scopolamine-induced rat model of AD by assessing spatial memory using the Morris Water Maze (MWM) test and passive avoidance test, as well as measuring oxidative stress markers, including the Ferric-Reducing Ability of Plasma (FRAP) and Malondialdehyde (MDA) levels. Results: The selected formula (F2) of chitosan-coated SeNPs significantly improved spatial memory and reduced oxidative stress markers compared to scopolamine controls, suggesting a synergistic effect. The average size of F2 was approximately 200 nm, with a zeta potential of-20.4 mV. The loading efficiency of donepezil into F2 was 42.3±0.57%. In the MWM test, F2 significantly improved spatial memory and learning compared to the scopolamine group (p<0.01). F2 also ameliorated scopolamine-induced memory deficits in the passive avoidance test (p<0.05). Furthermore, F2 significantly increased FRAP levels and decreased MDA levels in both serum and brain tissue compared to the scopolamine group (p<0.05). Conclusion: The results suggest that chitosan-coated SeNPs may offer a promising therapeutic approach for AD by targeting both oxidative stress and cholinergic dysfunction, warranting further investigation.
Introduction: Due to the high prevalence and drug resistance reported for the influenza virus in recent years, much research is being conducted on the discovery and introduction of more effective drugs against the virus. In this regard, the present bioinformatics study examined the inhibitory effects of berberine, a plant-based alkaloid, on influenza virus neuraminidase using docking and molecular dynamics studies. Methods: To conduct this study, the three-dimensional structure and PDB file of influenza virus neuraminidase were prepared from the protein and molecular information database, and the structure file of the berberine and oseltamivir (as positive control) molecules were prepared from the PubChem database. Using GROMACS software, simulation and molecular dynamics calculations were performed in the absence of an inhibitor. Molecular docking studies were performed using AutoDock software, and re-simulation of the protein-ligand complex was performed using GROMACS software. Results: Berberine was bound to the neuraminidase molecule with three hydrogen bonds and eleven hydrophobic bonds at the binding site. The amount of binding energy (BE) of berberine and oseltamivir was equal to -7.93 and -6.27 kcal/mol with the estimated inhibition constant (EIC) of 1.5 and 25.2 μM, respectively. Over simulation time, the radius of gyration (Rg) of the enzyme at berberine binding increased, but there was no significant difference in system energy changes (TE). Conclusion: Due to berberine binding, structural changes occur in the secondary and tertiary structures of influenza virus neuraminidase. The large number of created bonds, the low level of binding energy, and the low concentration of the EIC indicate the high tendency of berberine to bind to the binding site of neuraminidase.